English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/131010
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

Engineered nanoparticles for improved vasoactive intestinal peptide (VIP) biomedical applications

AutorKlippstein, Rebecca ; Pozo, David
Palabras claveVIP
VIP receptors
Surface funcionalization
Immunomodulation
Neuropeptide
Cancer
Fecha de publicación2011
EditorBentham Science Publishers
CitaciónRecent Patents on Nanomedicine 1(1): 55-59 (2011)
ResumenNanotechnology can address key bottlenecks hindering successful bench to bedside translation of recent research in the development of neuropeptide-based drugs. This is the case for vasoactive intestinal peptide (VIP), where sustained interest in its therapeutic applications needs to devise new methodologies to improve its drugability or to convey innovation to diagnostics to identify cells that result from conditions such as carcinoid metastasis in which VPAC receptors are involved. We analyze here current technologies and patent disclosing methods on surface functionalization or encapsulation to obtain VIP engineered nanoparticles.
URIhttp://hdl.handle.net/10261/131010
Identificadoresissn: 1877-9123
e-issn: 1877-9131
Aparece en las colecciones: (CABIMER) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.